Current Pharmaceutical Biotechnology
Title:Meet the Editorial Board Member
Volume: 23 Issue: 8
Author(s): Suresh Kumar
Affiliation:
Export Options
About this article
Cite this article as:
Kumar Suresh, Meet the Editorial Board Member, Current Pharmaceutical Biotechnology 2022; 23 (8) . https://dx.doi.org/10.2174/138920102308220331115530
DOI https://dx.doi.org/10.2174/138920102308220331115530 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Repurposing of Fluvastatin Against Candida albicans CYP450 Lanosterol 14 α-demethylase, a Target Enzyme for Antifungal Therapy: An In silico and In vitro Study
Current Molecular Medicine FDG-PET in Tuberculosis
Current Molecular Imaging (Discontinued) Tuberculosis Deaths Among Populations with High HIV Prevalence
Current Respiratory Medicine Reviews Glutamate and Schizophrenia
Current Neuropharmacology Electrotransfer into Skeletal Muscle for Protein Expression
Current Gene Therapy Metabolic Imaging through Continuous In Situ Micro-extractions of Tissue Samples via Flowprobe Mass Spectrometry
Current Metabolomics Pharmacological Aspects and Potential Use of Phloretin: A Systemic Review
Mini-Reviews in Medicinal Chemistry Population Pharmacokinetics and its Role in Anti-Tuberculosis Drug Development and Optimization of Treatment
Current Pharmaceutical Design Developments of Corey-Chaykovsky in Organic Reactions and Total Synthesis of Natural Products
Current Organic Synthesis Recent Advances in New Structural Classes of Anti-Tuberculosis Agents
Current Medicinal Chemistry Reverse Pharmacognosy: Another Way to Harness the Generosity of Nature
Current Pharmaceutical Design Polypharmacology in a Single Drug: Multitarget Drugs
Current Medicinal Chemistry Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison
Infectious Disorders - Drug Targets How Would Composite Traditional Chinese Medicine Protect the Brain – An Example of the Composite Formula “Pien Tze Huang”
Current Medicinal Chemistry Synthesis, Spectroscopic, In-vitro and Computational Analysis of Hydrazones as Potential Antituberculosis Agents: (Part-I)
Combinatorial Chemistry & High Throughput Screening Synthesis and Antitubercular Activity of a Series of Thiazole Derivatives
Anti-Infective Agents Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets Quinoxaline 1,4-di-N-Oxide Derivatives: Are They Unselective or Selective Inhibitors?
Mini-Reviews in Medicinal Chemistry Analysis of Capsaicinoids in Hot Sauces Using a Silica Hydride-Based Stationary Phase
Current Chromatography